News

September 30th, 2024

Co-Founder Dr. Scott Hollenbeck, MD named President of ASPS

Scott Hollenbeck, MD, co-founder of inSoma Bio, has been named president of the American Society of Plastic Surgeons (ASPS), the world’s largest organization of board-certified plastic surgeons, representing more than 11,000 members globally. Dr. Hollenbeck took office on September 29, 2024, during the Society’s annual meeting in San Diego. As president, Dr. Hollenbeck aims to highlight the fundamental value of plastic surgery in the U.S. healthcare system, advocating for enhanced patient safety, ensuring access to services, and promoting the importance of consulting board-certified surgeons for cosmetic or reconstructive procedures. A leader in academic medicine and innovation, we are incredibly proud to work alongside him and his vision for a better future for patients

Read whole article
June 20th, 2024

Dr. Heather Brennan Joins inSoma Board of Directors

inSoma is pleased to announce the addition of Heather Brennan, Ph.D., to its Board of Directors. Dr. Brennan is passionate about women’s health and has 20 years of medical device and regenerative medicine experience. She currently serves as CEO of PracticeWise, a behavioral health company. Prior to PracticeWise, Dr. Brennan was General Manager, Global Markets at Establishment Labs where she managed a $165M global breast reconstruction and aesthetics business. She also previously served as Vice President and General Manager of MTF Biologics’ Plastic and Reconstructive Surgery Franchise, where she developed and led the strategic direction of the business, growing revenue by 500% and solidifying a leadership spot for the company in post-mastectomy breast reconstruction. Dr. Brennan received her Ph.D. in biomedical engineering from Rutgers University and her bachelor’s degree in mechanical engineering from Lehigh University.

February 28th, 2024

inSoma Appoints Head of Regulatory Affairs

inSoma is pleased to welcome Thalia Charles as its Head of Regulatory Affairs. In this role, Ms. Charles will support the advancement of inSoma’s regenerative reconstruction platform, Fractomer™, into clinical evaluation for its potential as a safe and natural option for patients opting for reconstruction. She brings 20 years’ experience steering medical devices through agency oversight to market, and deep expertise in the reconstruction and augmentation regulatory environment. Ms. Charles joins inSoma from Establishment Labs where she served as Senior Director of Global Regulatory Affairs. Prior to Establishment Labs, she served as Director of Regulatory Affairs for TransMedics, Inc. Across her career, she has successfully navigated the regulatory landscape for products including donor organ preservation systems, cancer screening products, and coagulopathy testing. She received her Master’s in developmental psychobiology from Indiana University–Bloomington and her B.S. in psychology from Brown University.